Please assess the completion status of the following clinical trial:

Trial Title: Percocet vs. Bupivicaine for Toothaches in the ED

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who present to the ED with a chief complaint of toothache, and a pain intensity rating of at least a 7 on an 11 item verbal numeric scale (from 0 or no pain to 10 or worst imaginable pain) will be eligible for enrollment.~* Patient should have the capacity to provide informed consent.~Exclusion Criteria:~* Patients presenting with a toothache due to trauma or post-operative procedure will be excluded as well as those requiring drainage of a dental abscess.~* Patients who have any contraindications to the medications used in the study (allergy, history of GI bleeding, etc.).~* Patients who cannot remain in the ED for at least 1 hour after study drug administration or do not have a ride home (if receiving Percocet) will be excluded from the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Oral analgesic (Type: ACTIVE_COMPARATOR): 2 tablets of acetaminophen 325 mg/ oxycodone 5 mg orally once
- Injectable local anesthetic (Type: EXPERIMENTAL): local injection or nerve block with bupivicaine 0.5%

Based on this trial design, predict the completion outcome and termination type (if applicable).